The United States on Wednesday authorized the use of boosters of Pfizer’s COVID-19 vaccine for people aged over 65, or adults at high risk of severe disease as well as those in high-exposure jobs.
Coronavirus
Agence France-Presse: US okays Pfizer COVID-19 booster for the elderly, high-risk
In this file photo taken on March 11, 2021 a man wearing facemask and shield walks past the Pfizer headquarters in New York one year after the pandemic was officially declared.
